Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
…
continue reading
Welcome to the Power Pod, a space to elevate your life and help you feel more powerful. My name is Alexa and I am the host of this podcast and #1 best selling author of Power to Persevere: Inspiring Stories to Help You Get Through Challenging Moments. My goal is to help improve your life through wellness tips and motivation, and support you on your journey through life. Make sure you stay tuned for new episodes weekly. Connect with me on Instagram @alexacuc and alexacuc.com
…
continue reading
Life is messy, so a dash of chaos is enough to set you over the edge. You're not alone. There's a lot of things in life to experience, and I'm fairly certain I've had my share. I'm a single mom who works full-time, raising two boys, one on the spectrum, and in between all that I managed to find myself on the PTSA board, starting a nonprofit, and doing piles of laundry. Prior to this madness I had to deal with fighting Non-Hodgkin's lymphoma. I'm currently working on weight loss, meditation, ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Selecting Antiseizure Medications and Aiming for Seizure Freedom
38:05
38:05
Play later
Play later
Lists
Like
Liked
38:05
How to achieve seizure freedom after 2 antiseizure medications (ASMs) fail? Expert insight into best practice Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001425?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Advances in Dermal Fillers: Hybrid Fillers and the Power of Regenerative Biostimulation
32:15
32:15
Play later
Play later
Lists
Like
Liked
32:15
Learn the fundamentals of regenerative aesthetics and how hybrid fillers can help you achieve patient goals. Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001440?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Treatment Goals and Targeted Therapies in Myasthenia Gravis
31:03
31:03
Play later
Play later
Lists
Like
Liked
31:03
Are you up to date on the most recent clinical guidelines and treatment options for myasthenia gravis (MG)? Credit available for this activity expires: 8/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001404?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway
37:22
37:22
Play later
Play later
Lists
Like
Liked
37:22
How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024. Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_msc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
49:32
49:32
Play later
Play later
Lists
Like
Liked
49:32
In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care
38:15
38:15
Play later
Play later
Lists
Like
Liked
38:15
Learn from the experts about aligning treatments with patient expectations at first relapse of diffuse large B-cell lymphoma (DLBCL). Credit available for this activity expires: 7/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001321?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Incorporating Lipoprotein(a) Routinely Into Cardiovascular Risk Assessment: Why, What, Who, How, and When?
18:49
18:49
Play later
Play later
Lists
Like
Liked
18:49
Learn from the experts about typical clinical scenarios, guidelines, and practical tips about lipoprotein(a) [Lp(a)]. Credit available for this activity expires: 7/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001247?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs
34:45
34:45
Play later
Play later
Lists
Like
Liked
34:45
In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Current Clinical Practice and NCCN Guidelines for CLL/SLL
31:33
31:33
Play later
Play later
Lists
Like
Liked
31:33
In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Results from the phase II CAPTIVATE trial Choosing among th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today
29:49
29:49
Play later
Play later
Lists
Like
Liked
29:49
Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date? Credit available for this activity expires: 7/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001332?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Exploring the Value of Delivering Lung Cancer Medicines in Different Ways: Optimizing the Patient Experience
41:57
41:57
Play later
Play later
Lists
Like
Liked
41:57
New subcutaneous (SC) therapies are becoming available in lung cancer. Are you ready to talk to your patients about these? Credit available for this activity expires: 7/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001272?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs
28:35
28:35
Play later
Play later
Lists
Like
Liked
28:35
In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the M…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
24:23
24:23
Play later
Play later
Lists
Like
Liked
24:23
In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL Key ongoing clinical trials of CELMoDs in NHL Strategies to…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Latest Advances in Breast Cancer Care: Highlights From Chicago 2024
16:37
16:37
Play later
Play later
Lists
Like
Liked
16:37
Missed the last oncology meeting in Chicago or simply want to recap the highlights? This rapid-fire program was made for you! Credit available for this activity expires: 7/9/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001283?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
24:30
24:30
Play later
Play later
Lists
Like
Liked
24:30
In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest data on incorporating CDK4/6 inhibitors into treatment plans for patients with HR+/HER2- breast cancer. Topics in this podcast include: Evidence from the monarchE and NATALEE trials of adjuvant abemacicli…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Congress to Clinic: Expert Takeaways on Emerging Data for AML
25:21
25:21
Play later
Play later
Lists
Like
Liked
25:21
In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: Data from the prospective, single-center phase Ib/II study of FLAG-IDA plus venetoclax in newly diagnosed or relapsed/refractor…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Congress to Clinic: Expert Takeaways on Emerging Data for MDS
19:19
19:19
Play later
Play later
Lists
Like
Liked
19:19
In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic syndromes (MDS) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: COMMANDS trial of luspatercept in transfusion-dependent, erythropoietin stimulating agent–naive, very low…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Obesity Care: Improving Health Outcomes in Collaboration With the Patient
35:14
35:14
Play later
Play later
Lists
Like
Liked
35:14
What impact can weight loss have on the lives of your patients living with obesity? What treatment options are available to help you help them? Credit available for this activity expires: 06/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001269?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Evolution of Incretins – A Revolution in Diabetes Management?
35:55
35:55
Play later
Play later
Lists
Like
Liked
35:55
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice? Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001235?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dengue: A Leading Cause of Travel-Related Fever – Vaccinating Travelers to Endemic Regions
20:34
20:34
Play later
Play later
Lists
Like
Liked
20:34
Are you up to date on the risk for dengue and how to implement dengue vaccination in travelers to endemic regions? Credit available for this activity expires: 6/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001216?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unlocking the Power of Tumor-Agnostic Therapy: A Path to Personalized Cancer Care
36:04
36:04
Play later
Play later
Lists
Like
Liked
36:04
Are you aware of the currently approved tumor-agnostic drugs? Listen to the experts as they discuss them. Credit available for this activity expires: 06/21/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001234?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multiple Sclerosis Biosimilars in Europe: How to Communicate With Your Patient for Successful Implementation
20:17
20:17
Play later
Play later
Lists
Like
Liked
20:17
Did you know that specific words and gestures you use can cause the nocebo effect? Credit available for this activity expires: 6/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000861?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A Deep Dive Into Long-Term Efficacy and Safety of LDL-Cholesterol Lowering: Modern Strategies for ASCVD
31:41
31:41
Play later
Play later
Lists
Like
Liked
31:41
Are you up to date on low-density lipoprotein cholesterol (LDL-C)–lowering therapy in high-risk patients? Credit available for this activity expires: 06/06/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000828?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Antibody-Drug Conjugates in the Spotlight: Novel Strategies for Breast Cancer Management
37:59
37:59
Play later
Play later
Lists
Like
Liked
37:59
Are you up to date on the key clinical data on ADCs in breast cancer -- especially those that set the stage for upcoming data releases? Credit available for this activity expires: 5/31/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000851?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Decoding Epilepsy Treatment Strategies: A Case-Based Exploration
20:33
20:33
Play later
Play later
Lists
Like
Liked
20:33
Combining data, guidelines, and experience to select appropriate treatments for individuals with focal epilepsy. Credit available for this activity expires: 5/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000865?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Delivering Precision Oncology to Patients: From Principles to Practice
31:31
31:31
Play later
Play later
Lists
Like
Liked
31:31
How can molecular profiling guide cancer therapy? Join our experts to learn how to best utilize molecular testing in clinical practice. Credit available for this activity expires: 5/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001132?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chronic Inflammatory Demyelinating Polyneuropathy: How Insights From Disease Biology Inform Novel Therapies
32:33
32:33
Play later
Play later
Lists
Like
Liked
32:33
Did you know that more than 20% of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) do not respond to current first-line treatments? Credit available for this activity expires: 5/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000839?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Keeping Your Head Up and Fostering Strength With Matthew @MattyBowels Ulcerative Colitis Awareness & My Cancer Experience with Hodgkin's Lymphoma AYA Cancer Survivor
1:11:18
1:11:18
Play later
Play later
Lists
Like
Liked
1:11:18
Matt dives into his experience with UC and the following topics/ themes: Having a second chance at life Surviving life weighing 101 - 111 lbs as a 5'7 male Colonoscopy/ j-pouch surgery and complications Maintaining a positive mindset Advocating for your health Finding the right medical team Power of prayer and synchronicities Fostering friendships …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Poverty to Abundance and Entrepreneurship Through Law of Attraction with Sabrina @betteryoubysabrina
32:26
32:26
Play later
Play later
Lists
Like
Liked
32:26
Sabrina, Spiritual Mindset Mentor and Coach, and I have a discussion on creating reality. Tune in to learn how to work with Sabrina."Following your intuition is like walking through thick fog."From poverty to abundanceVictim mindsetBlacking out from drinkingChanging your environmentJournalingChronic anxiety and depressionListening to your intuition…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
(2/2) The Importance of Human Connection in Marketing and Business, Dealing with Rejection, and Learning From Your Challenges w/ Danielle Becker @leftysrightmind
25:12
25:12
Play later
Play later
Lists
Like
Liked
25:12
Part two is here! Topics include: Importance of human connection What is sourcing? Overcoming challenges and embracing the unknown How to deal with rejection Favorite collaborations Ralph Lauren Fashion Week, Marie Claire Habits and Lifestyle ZodiacsAnswering Questions:✨Advice for aspiring artists/ entrepreneurs:- How do you find yourself as an art…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
(1/2) Growing Your Creative Agency and Turning Your Passion into a Business w/ Danielle Becker @leftysrightmind
21:32
21:32
Play later
Play later
Lists
Like
Liked
21:32
Meet Danielle, CEO and Founder of Lefty’s Right Mind, a bespoke creative studio. IG: @leftysrightmindTopics include: Starting a career at Aeropostale, Hanes, Champion, Nike, Walmart Discovering your identity through motherhood and balancing careerLefty’s Right Mind is a full-service, bespoke atelier that brings a client’s vision to life through cre…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Thriving in Your 20s - Approach Health Through a Place of Love and Curiosity, Dietetics, Hormonal Balance, Blood Sugar Regulation with Ava Nouri
49:41
49:41
Play later
Play later
Lists
Like
Liked
49:41
Topics include: Approach health through a place of love and curiosity The intentionality of food choices from a place of love, gratitude, and intention Is meat actually bad for you? Thoughts on veganism Normalizing your blood sugar to prevent hanger What a balanced meal looks like Protein powder - whey versus pea Heme versus non-here iron Build the…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice
34:51
34:51
Play later
Play later
Lists
Like
Liked
34:51
What are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey. Credit available for this activity expires: 5/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001127?ecd=bdc_podcast_libsyn…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Evolving Perspectives on HR-Positive Metastatic Breast Cancer: Current Understanding and New Insights
34:45
34:45
Play later
Play later
Lists
Like
Liked
34:45
Are you up to date on the latest developments in hormone receptor-positive metastatic breast cancer? Listen to our expert panel to find out more! Credit available for this activity expires: 05/20/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000713?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
25:55
25:55
Play later
Play later
Lists
Like
Liked
25:55
In this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the landmark EMERALD study that led to FDA approval of elacestrant, the first oral selective estrogen receptor degrader (SERD) for treatment of hormone receptor–positive/HER2-negative metastatic breast canc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question
28:11
28:11
Play later
Play later
Lists
Like
Liked
28:11
Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)? Credit available for this activity expires: 5/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
47:23
47:23
Play later
Play later
Lists
Like
Liked
47:23
In this episode, Danielle M. Brander, MD; Deborah Stephens, DO; and Brian Hill, MD, PhD, discuss key aspects of the NCCN CLL guidelines and share strategies for applying these recommendations in your clinical practice to optimize treatment and outcomes. The greater discussion addresses: Optimal selection of therapy for treatment-naive CLL, includin…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Personalizing Care for Breast Cancer: The Precision Medicine Approach
34:42
34:42
Play later
Play later
Lists
Like
Liked
34:42
Do you really know the optimal biomarker tests for personalizing breast cancer treatment? Are some just unnecessary? Find out from the experts! Credit available for this activity expires: 4/30/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000564?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A Roadmap to Relief: Managing Agitation in Dementia Associated With Alzheimer's Disease
1:00:25
1:00:25
Play later
Play later
Lists
Like
Liked
1:00:25
Do you know the symptoms that affect more than 80% of people with Alzheimer's disease in some countries? Credit available for this activity expires: 04/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000723?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow
37:49
37:49
Play later
Play later
Lists
Like
Liked
37:49
Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with chronic lymphocytic leukemia (CLL)? Experts discuss the key differentiators and upcoming developments in the field. Credit available for this activity expires: 04/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/10007…
…
continue reading
Are you looking for practical advice on using ileal bile acid transporter (IBAT) inhibitors in clinical practice? Credit available for this activity expires: 4/16/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000397?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?
20:53
20:53
Play later
Play later
Lists
Like
Liked
20:53
How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out. Credit available for this activity expires: 03/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462 ?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
48:15
48:15
Play later
Play later
Lists
Like
Liked
48:15
In this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing to guide treatment decisions in advanced prostate cancer, with topics including: Rationale for targeting PARP in prostate cancer with ARI combinations Study design nuances and findings from key randomiz…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Connecting the Clinical Clues of Alagille Syndrome
28:17
28:17
Play later
Play later
Lists
Like
Liked
28:17
Do you know the key features of Alagille syndrome and how therapies that target the bile acid cycle can improve clinical symptoms? Credit available for this activity expires: 3/26/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000514?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Patient With Obesity in Primary Care: Novel Strategies for Sustained Weight Loss and Better Health Outcomes
17:39
17:39
Play later
Play later
Lists
Like
Liked
17:39
Do you know how to spot when a patient needs more than lifestyle approaches for weight loss? Credit available for this activity expires: 3/1/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000272?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Physical Implications of Stigma in People Living With HIV
32:08
32:08
Play later
Play later
Lists
Like
Liked
32:08
What are the clinical and cellular effects of stigma in your patients living with HIV? Credit available for this activity expires: 3/13/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000379?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer
36:29
36:29
Play later
Play later
Lists
Like
Liked
36:29
In this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for patients with unresectable or metastatic HER2-low, hormone receptor–positive, and triple-negative breast cancer, including: Challenges with the pathologic testing for HER2-low expression Optimal treatmen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
HER2-Positive Metastatic Colorectal Cancer: Unraveling Game-Changing Treatment Approaches
36:12
36:12
Play later
Play later
Lists
Like
Liked
36:12
Listen to the experts as they share the latest findings on HER2-directed therapies in the treatment of HER2-positive metastatic colorectal cancer (mCRC). Credit available for this activity expires: 2/28/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000191?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Patient With High CV Risk and Obesity in Cardiology Care: Evidence-Based Strategies for Weight Loss and CV Risk Reduction
22:34
22:34
Play later
Play later
Lists
Like
Liked
22:34
Do you know how to reduce cardiovascular (CV) risk in your patients living with obesity? What does the evidence show? Credit available for this activity expires: 3/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000273?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unveiling the Bigger Picture of Alzheimer's Disease: From New Disease Mechanisms to Biomarkers
33:41
33:41
Play later
Play later
Lists
Like
Liked
33:41
Do you know all there is to know beyond amyloid and tau in Alzheimer's disease? Credit available for this activity expires: 02/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000023?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading